| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/06/2008 | US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080057540 Novel DKR polypeptides |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057124 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057073 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 03/06/2008 | US20080057071 Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer |
| 03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057068 SARMS and method of use thereof |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057032 Combination therapy (temozolomide and alpha-ifn) for advanced cancer |
| 03/06/2008 | US20080057029 Administering cell expressing a cytokine from a recombinant polynucleotide, where the cells has been inactivated to prevent proliferation; a mixture of antigen and genetic engineered allogenic cell |
| 03/06/2008 | US20080056990 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 03/06/2008 | DE102006041525A1 Use of ginger to slow or reverse the growth of rapidly developing tumors in animals and humans |
| 03/06/2008 | CA2666469A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| 03/06/2008 | CA2662285A1 Raf inhibitor compounds and methods of use thereof |
| 03/06/2008 | CA2662196A1 Inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | CA2662164A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | CA2662140A1 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| 03/06/2008 | CA2662126A1 Anti cancer use of caffeic acid and its derivatives |
| 03/06/2008 | CA2662074A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | CA2662038A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 03/06/2008 | CA2661833A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/06/2008 | CA2661803A1 Antibodies, assays and hybridomas |
| 03/06/2008 | CA2661702A1 Method for producing phenoxypyridine derivative |
| 03/06/2008 | CA2661288A1 Carbamoylsulphoximides as protein kinase inhibitors |
| 03/06/2008 | CA2660806A1 5-substituted isoindoline compounds |
| 03/06/2008 | CA2660376A1 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 03/06/2008 | CA2659352A1 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 03/06/2008 | CA2657469A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/05/2008 | EP1895012A1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1894931A1 Triazole derivatives as kinase inhibitors |
| 03/05/2008 | EP1894924A1 Heterocyclic FXR binding compounds |
| 03/05/2008 | EP1894921A2 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof |
| 03/05/2008 | EP1894918A1 Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same |
| 03/05/2008 | EP1894917A1 Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer |
| 03/05/2008 | EP1894916A2 Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the efficiency of cytostatics and metastasis process inhibiting method |
| 03/05/2008 | EP1894575A1 Therapeutic agent for cancer |
| 03/05/2008 | EP1894574A1 Anti-cancer agent comprising protein c inhibitor |
| 03/05/2008 | EP1894569A2 Tetracycline derivatives for treating cancer |
| 03/05/2008 | EP1893612A1 Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors |
| 03/05/2008 | EP1893611A1 Ergoline derivatives and their use as chemokine receptor ligands |
| 03/05/2008 | EP1893598A1 Alkylquinoline and alkylquinazoline kinase modulators |
| 03/05/2008 | EP1893561A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents |
| 03/05/2008 | EP1893224A1 Use of plant cell membrane for the for the treatment of obesity |
| 03/05/2008 | EP1893215A1 Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators |
| 03/05/2008 | EP1893214A1 Synergistic modulation of flt3 kinase using alkylquinolines and alkylquinazolines |
| 03/05/2008 | EP1893213A1 Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 03/05/2008 | EP1893211A1 Use of sanglifehrin in hcv |
| 03/05/2008 | EP1893210A2 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 03/05/2008 | EP1893209A2 4-anilino-3-quinolinecarbonitriles for the treatment of cancer |
| 03/05/2008 | EP1893206A2 Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
| 03/05/2008 | EP1893199A2 Pdz-domain modulators |
| 03/05/2008 | EP1893198A2 Treatment of liver diseases in which iron plays a role in pathogenesis |
| 03/05/2008 | EP1893196A1 Diarylhydantoin compounds |
| 03/05/2008 | EP1805175B1 Novel azaindole thiazolinones as anti-cancer agents |
| 03/05/2008 | EP1653943B1 Catechol derivatives for the treatment of cancer |
| 03/05/2008 | EP1411919B1 (-)-olivil as antioxidant |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1238985B1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP1207904B1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/05/2008 | EP1059942B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | CN101137673A Cripto结合分子 Cripto binding molecules |
| 03/05/2008 | CN101137671A Anti-igsf4 antibody and utilization of the same |
| 03/05/2008 | CN101137659A Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |
| 03/05/2008 | CN101137634A Semi-synthetic taxane derivatives with antitumor activity |
| 03/05/2008 | CN101137396A Production of bioactive glycoproteins from inactive starting material |
| 03/05/2008 | CN101137392A Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 03/05/2008 | CN101137391A Recombinant super-compound interferon and uses thereof |
| 03/05/2008 | CN101137386A Method of treating liver cancer |
| 03/05/2008 | CN101137364A Compositions comprising an epothilone and production methods |
| 03/05/2008 | CN101137360A Anti-proliferative combination therapy comprising satraplatin or JM118 and a taxane |
| 03/05/2008 | CN101134779A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/05/2008 | CN101134778A Monoclonal antibody of esophagus cancer resistant blood vessel endothelium cell |
| 03/05/2008 | CN101134768A Method for refining cucurbitacin raw material and preparation thereof |
| 03/05/2008 | CN101134724A 1'-acetoxy chavicol acetate |
| 03/05/2008 | CN101134601A Novel water-soluble platinum (ó) small molecule anticancer complex |
| 03/05/2008 | CN101134110A Q type non-viral vector and pharmaceutical composition containing the same |
| 03/05/2008 | CN101134109A Anticancer prior-medicine and method for preparing the same and use thereof |
| 03/05/2008 | CN101134102A 5T4 tumour-expressed antigen |
| 03/05/2008 | CN101134101A 5T4 tumour-associated antigen |
| 03/05/2008 | CN101134089A Traditional Chinese medicine for treating cancer of the esophagus |
| 03/05/2008 | CN101134057A Compound medicament of natural plant extract containing paclitaxel and anticancer application thereof |
| 03/05/2008 | CN101134046A Application of TLR4 and TLR9 agonist compound in the restraint of tumour metastasis |
| 03/05/2008 | CN101134026A Vinorelbine soft capsule and method for preparation and application thereof |
| 03/05/2008 | CN101134024A Hydrochloric acid ondansetron oral cavity disintegrating lyophilized tablets and method for preparing the same |
| 03/05/2008 | CN101133786A Wilding synthesized barley granules orange juice and method of processing the same |
| 03/05/2008 | CN100372862C Adriacin derivative with anti-cancer activity |
| 03/05/2008 | CN100372858C Method for refining oxaliplatin |